Shionogi Sets Up In Europe, To Develop Pipeline Before The "Crestor Cliff"

06 Jul 2012

• By John Davis

Anticipating the loss of royalties from Crestor in the next five years, Japanese innovator Shionogi continues its globalization process with a U.K. headquarters to pursue development of its late-stage research pipeline in Europe.

The Japanese pharmaceutical company Shionogi & Co. Ltd. has for the first time established a direct business presence in Europe, by setting up its European headquarters in London. The H.Q. will be involved across Europe in coordinating R&D, although the company has not yet decided whether it will have a commercial presence in each country or will market through partners.

The move is part of a globalization process that started with the acquisition of the U.S. company Sciele Pharma in...